According to GSEA analysis, NUAK1 was enriched in 29 different biochemical processes (Figure 6B), including human immunodeficiency virus 1 infection, transcriptional dysregulation in cancer, Th1 and Th2 cell differentiation and PD-L1 expression. This evidence concerns the gene NUAK1 and cancer.